SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2017 | Mar2016 | Mar2015 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹35 Cr | ₹8.29 Cr | ₹4.67 Cr | ₹-2.41 Cr | ₹0.68 Cr |
What is the latest Cash Flow from Financing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹35 Cr |
Mar2022 | ₹8.29 Cr |
Mar2017 | ₹4.67 Cr |
Mar2016 | ₹-2.41 Cr |
Mar2015 | ₹0.68 Cr |
How is Cash Flow from Financing Activities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹35 Cr | 321.95 | |
Mar2022 | ₹8.29 Cr | 77.66 | |
Mar2017 | ₹4.67 Cr | Positive | |
Mar2016 | ₹-2.41 Cr | Negative | |
Mar2015 | ₹0.68 Cr | - |
Compare Cash Flow from Financing Activities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,285.0 Cr | -2.6% | 23.5% | 129.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -2.6% |
23.5% |
129.3% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses